AzTrials
AzTrials

Refractive ErrorsNCT06884202

Evaluation of Delefilcon A Contact Lenses

A study testing Delefilcon A contact lenses with different base curves and diameters and Delefilcon A contact lenses with standard base curves and diameters in people with Refractive Errors and Myopia, run by Alcon Research at 16 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to evaluate the lens fit characteristics of delefilcon A contact lenses with different base curves and diameters. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Refractive Errors, Myopia
What is being tested?
Delefilcon A contact lenses with different base curves and diameters and Delefilcon A contact lenses with standard base curves and diameters
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
267 participants
Where
16 sitesUnited States
Study dates
28 Apr 2025to 26 Aug 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Successful wearer of spherical soft contact lenses in both eyes for a minimum of 5 days per week and a minimum of 6 hours per day during the past 3 months;
  • Able to wear contact lenses within a range of sphere powers from -2.00 and -4.00 diopters (D);
  • Best Corrected Visual Acuity (BCVA) (with manifest refraction) better than or equal to 0.10 logarithm Minimum Angle of Resolution (logMAR ) in each eye.

Who cannot join

  • Any anterior segment infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator;
  • History of refractive surgery or plan to have refractive surgery during the study, or irregular cornea in either eye;
  • Biomicroscopy findings at screening that are moderate (Grade 3) or higher and/or corneal vascularization that is mild (Grade 2) or higher; presence of corneal infiltrates.
  • Other protocol-defined inclusion/exclusion criteria may apply.

Trial locations and contacts

16 sites in 1 country.

16 sites in 1 country

United States16 sites
  • NC Eye Associates, OD, PLLC

    Apex, North Carolina, 27502

  • See Eye Care Optometry

    Charlotte, North Carolina, 28278

  • Coldwater Vision Research

    Coldwater, Mississippi, 38618

  • Eyeconic Family Eyecare

    Dallas, Georgia, 30157

  • ProCare Vision Centers, Inc.

    Granville, Ohio, 43023

  • Pearson Research Center, PA

    Longwood, Florida, 32779

  • Kurata Eyecare Center

    Los Angeles, California, 90013

  • Kindred Optics at Maitland Vision

    Maitland, Florida, 32751

  • Southern College of Optometry

    Memphis, Tennessee, 38104

  • SUNY College of Optometry Clinical Vision Research Center

    New York, New York, 10036

  • Elsa Pao, OD

    Oakland, California, 94607

  • Eyecare Professionals, Inc

    Powell, Ohio, 43065

  • Pacific Rims Optometry

    San Francisco, California, 94127

  • Dr. Schwartz Optometrist and Associates

    Sterling Heights, Michigan, 48312

  • West Bay Eye Associates

    Warwick, Rhode Island, 02888

  • Wyomissing Optometric Center

    Wyomissing, Pennsylvania, 19610

Other trials in United States

About this study

Official title: Clinical Evaluation of Overall Lens Fit of Delefilcon A Contact Lenses of Different Diameters and Base Curves

The purpose of the study is to evaluate the lens fit characteristics of delefilcon A contact lenses with different base curves and diameters.

Read the detailed description

Subjects will be expected to attend 4 office visits for an individual duration of participation of approximately 3 days.

Being tested
Delefilcon A contact lenses with different base curves and diameters, Delefilcon A contact lenses with standard base curves and diameters
Keywords
Contact lenses
Medical subject headings
Refractive Errors, Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Delefilcon A contact lenses with different base curves and diametersDevice

    Also called LID023681

    Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes with up to approximately 1.50 diopters (D) of astigmatism that does not interfere with visual acuity.

  • Delefilcon A contact lenses with standard base curves and diametersDevice

    Also called DAILIES TOTAL1®, LID006961

    Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes with up to approximately 1.50 diopters (D) of astigmatism that does not interfere with visual acuity.

Study groups in NCT06884202
Study groupRoleWhat they receive
LID023681, then LID006961OtherDelefilcon A contact lenses with different base curves and diameters worn in Period 1, followed by delefilcon A contact lenses with standard base curves and diameters worn in Period 2. During each period, the contact lenses will be worn bilaterally (in both eyes) for 6 (+2) hours. A one-to-two day washout will separate the wear periods.
Receives: Device: Delefilcon A contact lenses with different base curves and diameters; Device: Delefilcon A contact lenses with standard base curves and diameters
LID006961, then LID023681OtherDelefilcon A contact lenses with standard base curves and diameters worn in Period 1, followed by delefilcon A contact lenses with different base curves and diameters worn in Period 2. During each period, the contact lenses will be worn bilaterally (in both eyes) for 6 (+2) hours. A one-to-two day washout will separate the wear periods.
Receives: Device: Delefilcon A contact lenses with different base curves and diameters; Device: Delefilcon A contact lenses with standard base curves and diameters

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of Lenses Graded as Acceptably Tight, Optimal Fit, or Acceptably Loose at Dispense in Lens Movement (Overall Lens Fit) at Primary Gaze

    Lens movement was evaluated by the investigator using a slit lamp with the eye in primary gaze (looking straight ahead). Subject was asked to blink after which the investigator pushed up the lower lid margin to evaluate lens movement. Lens movement was graded on a 5-point scale as follows: -2 = unacceptably tight (reduced movement, unacceptable); -1 = Acceptably tight (reduced movement, acceptable); 0 = Optimal fit / movement; +1 = Acceptably loose (excessive movement, acceptable); +2 = Unacceptably loose (excessive movement, unacceptable). A grade of Acceptably Tight, Optimal Fit, or Acceptably Loose is considered to be acceptable lens fit.

    Measured: Day 1 Dispense (Hour 0) of each study lens type worn during the corresponding crossover period

  2. Proportion of Lenses Graded as Acceptably Tight, Optimal Fit, or Acceptably Loose at Dispense in Lens Movement (Overall Lens Fit) at Peripheral Gazes

    Lens movement was evaluated by the investigator using a slit lamp with the eye in peripheral gaze (upward gaze, downward gaze, looking to the left, and looking to the right). Lens movement was assessed for each gaze on a 5-point scale as follows: -2 = unacceptably tight (reduced movement, unacceptable); -1 = Acceptably tight (reduced movement, acceptable); 0 = Optimal fit / movement; +1 = Acceptably loose (excessive movement, acceptable); +2 = Unacceptably loose (excessive movement, unacceptable). The overall lens fit grade was based on the worst-case scenario among the different gazes. A grade of Acceptably Tight, Optimal Fit, or Acceptably Loose is considered to be acceptable lens fit.

    Measured: Day 1 Dispense (Hour 0) of each study lens type worn during the corresponding crossover period

  3. Proportion of Lenses Graded as Optimal Lens Centration or Acceptable Decentration at Dispense in Lens Position (Centration)

    Lens position was evaluated by the investigator using a slit lamp with the eye in primary position (relaxed, looking straight ahead). Lens position was graded on a 3-point scale as follows: 0 = Optimal centration; 1 = Acceptable decentration; 2 = Unacceptable decentration. A grade of Optimal Centration or Acceptable Decentration is considered to be acceptable centration.

    Measured: Day 1 Dispense (Hour 0) of each study lens type worn during the corresponding crossover period

  4. Proportion of Lenses Graded as Acceptably Tight, Optimal Fit, or Acceptably Loose at 6 Hour Follow-up in Lens Movement (Overall Fit) at Primary Gaze

    Lens movement was evaluated by the investigator using a slit lamp with the eye in primary gaze (looking straight ahead). Subject was asked to blink after which the investigator pushed up the lower lid margin to evaluate lens movement. Lens movement was graded on a 5-point scale as follows: -2 = unacceptably tight (reduced movement, unacceptable); -1 = Acceptably tight (reduced movement, acceptable); 0 = Optimal fit / movement; +1 = Acceptably loose (excessive movement, acceptable); +2 = Unacceptably loose (excessive movement, unacceptable). A grade of Acceptably Tight, Optimal Fit, or Acceptably Loose is considered to be acceptable lens fit.

    Measured: Day 1, Hour 6 (+2) of each study lens type worn during the corresponding crossover period

  5. Proportion of Lenses Graded as Acceptably Tight, Optimal Fit, or Acceptably Loose at 6 Hour Follow-up in Lens Movement (Overall Fit) at Peripheral Gazes

    Lens movement was evaluated by the investigator using a slit lamp with the eye in peripheral gaze (upward gaze, downward gaze, looking to the left, and looking to the right). Lens movement was assessed for each gaze on a 5-point scale as follows: -2 = unacceptably tight (reduced movement, unacceptable); -1 = Acceptably tight (reduced movement, acceptable); 0 = Optimal fit / movement; +1 = Acceptably loose (excessive movement, acceptable); +2 = Unacceptably loose (excessive movement, unacceptable). The overall lens fit grade was based on the worst-case scenario among the different gazes. A grade of Acceptably Tight, Optimal Fit, or Acceptably Loose is considered to be acceptable lens fit.

    Measured: Day 1, Hour 6 (+2) of each study lens type worn during the corresponding crossover period

  6. Proportion of Lenses Graded as Optimal Lens Centration or Acceptable Decentration at 6 Hour Follow-up in Lens Position (Centration)

    Lens position was evaluated by the investigator using a slit lamp with the eye in primary position (relaxed, looking straight ahead). Lens position was graded on a 3-point scale as follows: 0 = Optimal centration; 1 = Acceptable decentration; 2 = Unacceptable decentration. A grade of Optimal Centration or Acceptable Decentration is considered to be acceptable centration.

    Measured: Day 1, Hour 6 (+2) of each study lens type worn during the corresponding crossover period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2025
  2. Study start28 Apr 2025
  3. Primary completion26 Aug 2025
  4. Study completion26 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
267 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06884202
Sponsor's protocol ID
CLU484-P007
Status last verified
Aug 2026
First submitted
13 Mar 2025
Last updated
21 Aug 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Delefilcon A contact lenses with different base curves and diameters and Delefilcon A contact lenses with standard base curves and diameters in people with Refractive Errors and Myopia, run by Alcon Research at 16 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 16 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 21 Aug 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of Lenses Graded as Acceptably Tight, Optimal Fit, or Acceptably Loose at Dispense in Lens Movement (Overall Lens Fit) at Primary Gaze (time frame: Day 1 Dispense (Hour 0) of each study lens type worn during the corresponding crossover period). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in